Plain-English translation of NCT07047547 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a heart medication called in people who are on dialysis and also living with heart failure. has helped heart failure patients in other studies by improving heart function and reducing hospital stays. This study wants to see if the medication works well and is safe specifically for dialysis patients, who face unique challenges.
People on dialysis often develop heart failure, which makes their condition much harder to manage and their outlook worse. While this medication has been studied in heart failure patients before, researchers haven't done a focused study in dialysis patients yet, so there's a real need to understand whether the treatment works the same way for them.
You likely qualify if…
You likely don't qualify if…
You would start taking a low dose of the medication (2.5 mg once daily) for 2 weeks, then increase to a higher dose (5 mg once daily) if tolerated. Your doctors would monitor your blood pressure and adjust your other medications if needed. You would come back for follow-up visits over 12 months so the research team can check how you're doing, review your blood work, and make sure the medication is safe and helping your heart.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China